Humalog Mix 50/50 (insulin lispro protamine 50% + insulin lispro 50%)
/ Eli Lilly
- LARVOL DELTA
Home
Next
Prev
1 to 5
Of
5
Go to page
1
May 16, 2017
Humalog Mix50wmassive overdose for suicidal purpose: a case report
(ECE 2017)
- "The dose is correlated with a prolonged hypoglycemic risk higher than that deduced from the pharmacokinetics of insulin administered. To our knowledge this case represents the largest overdose with Humalog Mix50wever reported."
Clinical • Biosimilar • Cardiovascular • Depression • Diabetes • Diabetic Nephropathy • Obesity
November 22, 2013
Injection force and dose accuracy of FlexTouch for the delivery of a new basal insulin
(Expert Opin Drug Deliv)
- "...all tested doses from KP filled with insulin lispro mix 75/25 100 U/ml were within ISO limits, while some doses from SS filled with insulin glargine 100 U/ml were outside ISO limits. FT had a significantly lower injection force than SS and KP (p < 0.05)."
Clinical • Diabetes
February 25, 2020
Sexual Differences in response to Mid- or Low-Premixed Insulin Analogue in Patients with Type 2 Diabetes.
(PubMed, J Diabetes Res)
- "After screening, patients with longstanding T2D receive a 7-day continuous subcutaneous insulin infusion (CSII) therapy, and then subjects were randomly assigned 1 : 1 into two groups receiving Novo Mix 30 or Humalog Mix 50 regimen for a 2-day phage, followed by a 4-day cross-over period. Our data indicate that male patients with T2D receiving mid-premixed insulin analogue regimen may have a potential benefit of improvement in glycemic control compared to female patients. This trial is registered with ClinicalTrials.gov ChiCTR-IPR-15007340."
Clinical • Journal
March 28, 2019
Comparison of analog insulin mix 50:50 with human insulin mix 30:70 in persons with type 2 diabetes during Ramadan.
(PubMed, Int J Clin Pract)
- "Switching from human insulin mix 30:70 to analog insulin mix 50:50 results in better post main meal control in Ramadan, without affecting HbA1c, or increasing the incidence of hypoglycaemia."
Journal
September 04, 2019
COST-MINIMIZATION ANALYSIS OF INSULIN LISPRO 50/50 VERSUS INSULIN ASPART 30/70 PREMIXED FORMULATIONS IN TYPE II DIABETES
(ISPOR-EU 2019)
- "Insulin Mix Lispro 50/50 would be a dominant strategy compared to Insulin Mix Aspart 30/70 assuming the same product price."
HEOR
1 to 5
Of
5
Go to page
1